Caribou, in reversal, scraps autoimmune cell therapy and cuts staff

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid to focus resources on a pair of cancer cell therapies. 

Apr 25, 2025 - 14:54
 0
Caribou, in reversal, scraps autoimmune cell therapy and cuts staff

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid to focus resources on a pair of cancer cell therapies.